Erythropoietin Market Analysis And Report in Japan 2015-2019

Erythropoietin (EPO), also referred to as hematopoietin or hemopoietin, is a glycoprotein that is responsible for the production of erythrocytes in the body. In the fetal stage, this protein is produced in the liver. However, in adulthood it is produced in the kidneys.

During anemic conditions, the body produces an excess of erythropoietin to maintain a normal level of red blood cells. When the endogenous production of erythropoietin is disrupted because of illness or medications, normal red blood cell levels are maintained by an injecting erythropoiesis-stimulating agents (ESAs).

These agents are similar to natural erythropoietin in structure and function. They can be produced by recombinant DNA technology and are used in the treatment of anemia resulting from renal disease, cancer, HIV, injuries, or neurological conditions. The report analysts forecast the erythropoietin market in Japan to decline at a CAGR of (1.16) % over the period 2014-2019.

Covered in this Report:

In this report, it covers the present scenario and growth prospects of the erythropoietin market in Japan for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of erythropoietin drugs and biosimilars used in the treatment of anemia due to renal disease, chemotherapy, antiretroviral therapy, wounds, or neurological conditions.

To Read other reports of this category:
http://www.radiantinsights.com/catalog/pharmaceutical

Erythropoietin Market in Japan has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the erythropoietin market in Japan and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market.

Key vendors

•  Chugai Pharmaceutical
•  JCR Pharmaceuticals
•  Kissei Pharmaceutical
•  Kyowa Hakko Kirin

Other Prominent Vendors

•  Eisai
•  Otsuka
•  Taiho Pharmaceutical
•  Takeda

Market Driver

•  Increased incidence of anemia due to illness
•  For a full, detailed list, view our report

Market Challenge

•  High cost of therapy
•  For a full, detailed list, view our report

Market trend

•  Strategic alliances
•  For a full, detailed list, view our report

Key Questions Answered in this Report

•  What will the market size be in 2019 and what will the growth rate be?
•  What are the key market trends?
•  What is driving this market?
•  What are the challenges to market growth?
•  Who are the key vendors in this market space?
•  What are the market opportunities and threats faced by the key vendors?
•  What are the strengths and weaknesses of the key vendors?